Preview

Xian-Janssen Pharmaceutical (China ) and the Euro - Case Study

Better Essays
Open Document
Open Document
1300 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
Xian-Janssen Pharmaceutical (China ) and the Euro - Case Study
Xian-Janssen Pharmaceutical (China) and the Euro

How can the Chinese subsidiary of a multinational company both hedge its currency risks and still meet the sales and profitability objectives directed by leadership?

Paul Young was the financial controller of Xian-Janssen Pharmaceutical Ltd. (XJP), the Chinese subsidiary of the U.S.-based multinational, Johnson & Johnson.
Paul was preparing for a meeting with his CEO, Christian Velmer, which would focus on the business plan for the coming 2004 fiscal year.
XJP was expected by leadership (corporate) to generate 1.2 billion renminbi in earnings in 2004, a 20% increase over a highly successful 2003 year
This would be a challenge given that XJP was suffering from a number of rising expenses and foreign exchange losses
XJP of China
A joint venture, produces and marketed prescription and over-the-counter (OTC) medications to mostly hospitals in China (which made up roughly 80% of sales)
Most sales in the Chinese market were through tender sales, reverse auction markets in which companies produced bids for sales to individual hospitals and were awarded sales on the lowest cost bids (also termed a Dutch Auction in some places in the world)
XJP had closed 2003 with a 98% success rate on tenders
XJP purchased nearly 95% of all its product from Europe
Most product purchases from Europe were from J&J Europe, and therefore the prices were transfer prices – prices set internally within the company
Paul Young believed that most of the transfer prices XJP was paying were relatively high, increasing the profitability of the European business but increasing his costs in China (and therefore decreasing his profitability)
All European purchases were priced and invoiced in euros, and the euro had been rising significantly in value against the Rmb (since the Rmb was fixed to the dollar, and the dollar had been falling against the euro, the falling Rmb was a certainty)
All XJP payments for product from Europe were made

You May Also Find These Documents Helpful

  • Satisfactory Essays

    Trueblood Case 09 2

    • 804 Words
    • 2 Pages

    Company XYZ is an unrelated third-party private equity investor with no prior relationship or business operations related to Pharmagen…

    • 804 Words
    • 2 Pages
    Satisfactory Essays
  • Powerful Essays

    Accg326

    • 3574 Words
    • 15 Pages

    Two factors heavily influence the manner in which international transfer prices are determined: (a) corporate objectives, and (b) national tax laws. There are a variety of cost, especially tax, minimization objectives that MNCs might attempt to achieve through international transfer pricing. However, MNCs must be careful to comply with national tax laws in setting international transfer prices.…

    • 3574 Words
    • 15 Pages
    Powerful Essays
  • Powerful Essays

    cardinal health inc

    • 1287 Words
    • 4 Pages

    The case introduces us to the Cardinal Inc which for now is the leading manufacturer in the products of medical it has its own pharmaceuticals. Company is one of the fortune 500 companies the head office is in Dublin, Ohio. So, talking about pharmaceuticals and medical products its wide services offers to more than one hundred thousand locations. it does has its own products of medical and surgical it almost includes all the types of the surgical apparel and other equipment. so, what we can conclude is it is the largest medical company it has a wide coverage of almost 75% of hospitals in U.S.it has not only given services alone it has also some of the tie ups with other companies, so they are proven to be the best ,biggest and cheapest medical suppliers in U.S. So, beginning of their starting was a long back nearly 45 years long history is what they carried with them with the name of their own in the pharmaceuticals company. it actually serves as the middle person as it connects the providers and manufactures, we can view them as a broker too. The employees are more than 30000 all around the world but during their starting they have developed themselves as the cardinal Foods inc which they later diversified in to the medical products. The long term vision of Cardinal is to be the top leader in the name of medical and Pharmaceuticals Company through continuous development, innovation, research and development, scanning environment whereas the mission of them are to retain, collect and to identify the biggest opportunities in the market place. They want to be best by serving through the best to the customers they will to win the heart of the customers through their excellent service.…

    • 1287 Words
    • 4 Pages
    Powerful Essays
  • Powerful Essays

    Marketing Plan for Pharmasim

    • 3869 Words
    • 16 Pages

    The management team at the over-the-counter cold medicine (OCM) group of Allstar Brands is looking to utilize revenue generated by Allround to help fund new opportunities in emerging markets. Therefore, it is critical that Allround maintain its market-leading position in terms of market share, profitability, and sales in order to fund these new initiatives.…

    • 3869 Words
    • 16 Pages
    Powerful Essays
  • Powerful Essays

    IA1

    • 1931 Words
    • 6 Pages

    Quelch, J. Rodriquez, M. (2013). GlaxoSmithKline in China (A). Harvard Business School. Retrieved from https://cb.hbsp.harvard.edu/cbmp/content/34297188.…

    • 1931 Words
    • 6 Pages
    Powerful Essays
  • Good Essays

    Both houses need each other in order to function as they are both part of the legislative branch of government however there are many arguments to suggest that senate is more prestigious that the house of representatives.…

    • 1173 Words
    • 5 Pages
    Good Essays
  • Good Essays

    Case 7 Financial Detective

    • 1749 Words
    • 7 Pages

    Company A is Johnson & Johnson, which is a diversified manufacturer of prescription pharmaceuticals, health and beauty aids, over-the-counter drugs, and medical devices. Company B is Pfizer Inc., which develops, manufactures, and markets patented pharmaceuticals such as Liptor and Celebrex. The most significant strategic differences between the two firms lie in their product mix and their customer focus. J&J sells most of its products directly to the consumer while Pfizer sells exclusively to doctors and institutions.…

    • 1749 Words
    • 7 Pages
    Good Essays
  • Good Essays

    QI-TECH's local management was looking for a future partner that understands Chinese management style and can get along well with them. They worried the new partner might impose their foreign management style particularly with the loss of stakes of QQMF.…

    • 1002 Words
    • 5 Pages
    Good Essays
  • Best Essays

    The company focuses on the development of products related to health and well-being. The company has more than 275 companies, which are located in 60 different countries. It is the world’s sixth-largest consumer health company, the world’s eighth-largest pharmaceuticals company, the world’s fifth-largest biologics company, the world’s largest diagnostics company, and provides the world’s largest and most diverse medical devices (Our Company, n.d.)…

    • 889 Words
    • 4 Pages
    Best Essays
  • Best Essays

    Export.gov (June, 2007), Article: Sales Opportunities in China’s Medical Sector are Thriving, Retrieved September 25, 2008, from…

    • 1715 Words
    • 7 Pages
    Best Essays
  • Best Essays

    Johnson and Johnson Analysis

    • 3767 Words
    • 14 Pages

    The company is recognized as the 6th largest in the world for consumer health and the world largest providers of diverse medical diagnostic…

    • 3767 Words
    • 14 Pages
    Best Essays
  • Powerful Essays

    1. What is the brief history of the company and its line of business is it involved in?…

    • 2501 Words
    • 11 Pages
    Powerful Essays
  • Powerful Essays

    the market, followed by 36.4 percent for imports and 17.6 percent for joint venture products…

    • 20224 Words
    • 81 Pages
    Powerful Essays
  • Best Essays

    Telstra Strategy Report

    • 4463 Words
    • 18 Pages

    Cooper, L. (2000) Strategic Marketing Planning for Radically new Products, Journal of Marketing, Vol. 64 Issue 1, pp.1-15.…

    • 4463 Words
    • 18 Pages
    Best Essays
  • Good Essays

    In case of this company they have tried to combine the mutually supportive capabilities. They have tried to develop a business model by integrating the drug line and the production capabilities. Furthermore, packaging is arranged as a line hybrid process.…

    • 830 Words
    • 4 Pages
    Good Essays